Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Olic (Thailand) Limited is a leading Contract Development and Manufacturing Organization (CDMO) and pharmaceutical company based in Thailand. A subsidiary of Japan's Fuji Pharma, the company provides end-to-end manufacturing services for over 30 multinational pharmaceutical and healthcare organizations, specializing in diverse dosage forms including sterile injectables, soft gel capsules, and topicals. Beyond its core CDMO business, Olic has expanded into a hybrid model with its own Pharma Business unit, which licenses and commercializes innovative products, particularly in the field of women's healthcare. The company operates a state-of-the-art, PIC/S GMP-certified facility in the Bang Pa-In Industrial Estate and serves markets across Southeast Asia, Japan, the US, and Europe.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OLIC.